.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Novartis
McKinsey
Boehringer Ingelheim
Cantor Fitzgerald
Citi
McKesson
Colorcon
Accenture
Julphar

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021256

« Back to Dashboard
NDA 021256 describes CHIRHOSTIM, which is a drug marketed by Chirhoclin and is included in one NDA. It is available from one supplier. Additional details are available on the CHIRHOSTIM profile page.

The generic ingredient in CHIRHOSTIM is secretin synthetic human. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the secretin synthetic human profile page.

Summary for 021256

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021256

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHIRHOSTIM
secretin synthetic human
FOR SOLUTION;INTRAVENOUS 021256 NDA ChiRhoClin, Inc. 67066-005 67066-005-01 8 mL in 1 VIAL, SINGLE-USE (67066-005-01)
CHIRHOSTIM
secretin synthetic human
FOR SOLUTION;INTRAVENOUS 021256 NDA ChiRhoClin, Inc. 67066-007 67066-007-01 10 mL in 1 VIAL, SINGLE-USE (67066-007-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INTRAVENOUSStrength16MCG/VIAL
Approval Date:Apr 9, 2004TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INTRAVENOUSStrength40MCG/VIAL
Approval Date:Jun 21, 2007TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
UBS
Healthtrust
Daiichi Sankyo
Covington
US Army
QuintilesIMS
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot